Building for a
Sustainable Future

View our 2022 Corporate Values and
Sustainability Report.

Development Pipeline

Explore our broad clinical development program for cabozantinib.

Accelerating Innovation Through Partnership

High-impact relationships maximize results and expand possibilities.

Building for a Sustainable Future

View our 2022 Corporate Values and Sustainability Report.

Development Pipeline

Explore our broad clinical development program for cabozantinib.

Accelerating Innovation Through Partnership

High-impact relationships maximize results and expand possibilities.

Exelixis Expands East

Learn more about open roles and career opportunities to innovate oncology with us. Join our East Coast team.
Happy male scientist wearing protective eyewear

Resilient Together

Learn more about our journey of progress for 
patients and our efforts to translate drug discovery 
and development into breakthrough medicines.

Tackling Difficult-to-Treat Cancers

To date, we have three medicines available to treat certain types of kidney, liver and thyroid cancers and advanced melanoma.

Company Statement on COVID-19

Exelixis is actively monitoring the global COVID-19 pandemic, and remains steadfast in our commitment to the health and safety of our patients, customers, employees and local communities.